DBV Share Price

DBV Share Price

NASDAQ: DBVT | Small Cap | Healthcare
$9.01
-$0.42 (-4.4%) Last updated on 21 Nov, 2026 | 02:26 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

DBV Stock Performance

Open
$9.35
Prev. Close
$9.43
Circuit Range
N/A
Day Range
$9.01 - $9.43
Year Range
$8.65 - $26.15
Volume
5,827
Average Traded
$9.12

DBV Share Price Today

As of 22 November 2026, DBV Technologies S.A.'s share price is $9.01. The stock opened at $9.35, compared to its previous close of $9.43. During today's trading session, DBV Technologies S.A.'s share price traded between $9.01 and $9.43, with an average price of $9.22. Over the past 52 weeks, the stock has recorded a high of $26.15 and a low of $8.65. In terms of performance, DBV Technologies S.A.'s share price has declined by 52.93% over the last six months and is down 31.01% on a year-on-year basis.

DBV Share Price Chart

Line chart of the DBV price trend over the selected period. The price fell overall, ranging from 9.01 to 9.43, ending at 9.01.
$9.01$9.43
L
Show Current Price
H

DBV Stock Fundamentals & Key Indicators

Market Cap
$1.26B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.30
Revenue (TTM)
$5.64B
Return On Equity (TTM)
-139.43%
Profit Margin
-2605.50%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-43.88%

DBV Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.65$0.90$0.70$1.60
Net Profit-$44.83-$47.60-$50.40-$64.50
Net Profit Margin-6896.92%-5288.89%-7200.00%-4031.25%
Income ChangeN/A-6.18%-5.88%-27.98%

DBV Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4.84$15.73$4.15$5.64
Net Profit-$96.27-$72.73-$113.92-$146.95
Net Profit Margin-1989.05%-462.36%-2745.06%-2605.50%
Income ChangeN/A24.45%-56.63%-28.99%

DBV Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets20.821.2724.0723.44
Current Assets212.944.39158.92223.07
Total Assets233.765.66182.99246.52
Non Current Liabilities6.97.145.4622.54
Current Liabilities58.031.1437.3429.52
Total Liabilities64.938.2742.852.06
Shareholders' Equity168.827.39140.19194.46

DBV Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-121.18-104.47-79.65-55.67
Investing-1.37-0.76-0.81-0.1
Financing276.180.596.77194.12

Corporate Actions

Split
Ex-date: 29 Nov 2024

Split
Ex-date: 07 Jun 2024

About DBV

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

DBV Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$9.39
$9.01
-5.46%
Oct 2026
$11.32
$9.53
-19.10%
Sep 2026
$13.67
$11.78
-18.34%
Aug 2026
$13.22
$14.43
+7.09%
Jul 2026
$16.29
$13.47
-17.82%
Jun 2026
$18.37
$16.39
-14.37%
May 2026
$19.98
$19.14
-8.73%
Apr 2026
$21.35
$20.97
+0.05%
Mar 2026
$21.22
$20.96
+0.00%
Feb 2026
$22.14
$20.96
-3.08%
Jan 2026
$19.02
$21.63
+12.87%
Dec 2025
$13.35
$19.16
+46.71%

DBV Share Price FAQs